YonaLink, a clinical trial software supplier, said today that it has closed a $6 million inaugural fundraising round to scale global operations and expand its EHR-to-EDC connectivity platform. YonaLink’s SaaS service, designed to stream and map up-to-date patient data in real time, exports patient data straight from a clinical site’s EHR system and transfers it into clinical research electronic data capture (EDC) systems.
The round was led by the Swiss Debiopharm Innovation Fund. The European Union co-funded the investment, which also included Israel’s eHealth Ventures. The $6 million investment will be utilized to add more talent to the company’s expanding team, enhance the capabilities of the YonaLink platform, and push acceptance among clinical trial sponsors and their clinical research organization (CRO) partners.
YonaLink’s platform can stream current data from any clinical site’s EHR system in any location across the world and populate it within YonaLink’s next generation EDC or other data capture systems. YonaLink’s next generation EDC provides a full solution for today’s clinical trial demands, integrating EDC and eSource capability together in a single platform, with built-in eConsent and ePRO / eCOA and streaming EHR-to-EDC capabilities.